The mounting evidence of bacterial resistance against commonly prescribed antibiotics warrants the development of new antibacterial drugs on an urgent basis. Linezolid, an oxazolidinone antibiotic, is a lead molecule in designing new oxazolidinones as antibacterial agents. In this study, we report the antibacterial potential of the novel oxazolidinone-sulphonamide/amide conjugates that were recently reported by our research group. The antibacterial assays showed that, from the series, oxazolidinones 2 and 3a exhibited excellent potency (MIC of 1.17 μg/mL) against B. subtilis and P. aeruginosa strains, along with good antibiofilm activity. Docking studies revealed higher binding affinities of oxazolidinones 2 and 3a compared to linezolid, which were further validated by molecular dynamics simulations. In addition to this, other computational studies, one-descriptor (log P) analysis, ADME-T and drug likeness studies demonstrated the potential of these novel linezolid-based oxazolidinones to be taken forward for further studies.
Antibacterial Properties and Computational Insights of Potent Novel Linezolid-Based Oxazolidinones.
新型强效利奈唑胺基噁唑烷酮的抗菌特性及计算见解
阅读:5
作者:Malik M Shaheer, Faazil Shaikh, Alsharif Meshari A, Sajid Jamal Qazi Mohammad, Al-Fahemi Jabir H, Banerjee Amrita, Chattopadhyay Arpita, Pal Samir Kumar, Kamal Ahmed, Ahmed Saleh A
| 期刊: | Pharmaceuticals | 影响因子: | 4.800 |
| 时间: | 2023 | 起止号: | 2023 Mar 30; 16(4):516 |
| doi: | 10.3390/ph16040516 | 研究方向: | 其它 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
